Minimal residual disease alone not predictive in T-cell leukemia

14 mayo 2015

Researchers found that the presence of a few remaining leukemia cells, called minimal residual disease (MRD), at the end of induction chemotherapy was not predictive of risk or outcome in children with T-cell acute lymphoblastic leukemia (ALL). This opens the possibility for patients with T-cell ALL who have MRD to achieve complete remission without undergoing intensified cancer treatments and their associated toxicities.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/7Xz6MDhXlUI/150514121143.htm

Volver